Skip Navigation

Cardiovascular Research 2001 52(3):438-445; doi:10.1016/S0008-6363(01)00408-4
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Takahashi, M.
Right arrow Articles by Shimada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, M.
Right arrow Articles by Shimada, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes

Masafumi Takahashia,b,*, Jun Nishihirac, Masahisa Shimpoa, Yuka Mizuee, Shuichi Uenoa, Hiroyuki Manod, Eiji Kobayashib, Uichi Ikedaa and Kazuyuki Shimadaa

aDivision of Cardiology, Jichi Medical School, Tochigi, Japan
bDivision of Organ Replacement Research, Jichi Medical School, Tochigi, Japan
cCentral Research Institute, School of Medicine, Hokkaido University, Sapporo, Japan
dDivision of Functional Genomics, Jichi Medical School, Tochigi, Japan
eSapporo Immunodiagnostic Laboratory, Sapporo, Japan

* Corresponding author. Division of Cardiology, Jichi Medical School, Minamikawachi-machi, Tochigi 329-04, Japan. Tel.: +81-285-58-7344; fax: +81-285-44-5317 masafumi{at}jichi.ac.jp

Objective: Macrophage migration inhibitory factor (MIF), which plays a pivotal role in the control of inflammatory responses, was first characterized as a T-cell cytokine, but later was also found as a pituitary peptide released in response to infection and stress. However, MIF’s role and expression in the myocardium has never been reported. The goal of this study is to examine MIF in the myocardium. Methods and results: MIF protein and mRNA levels were assayed using enzyme-linked immunosorbent assay (ELISA) and reverse transcription–polymerase chain reaction (RT–PCR), respectively. Increased MIF concentrations were detected in the sera of patients with acute myocardial infarction (AMI). In cultured rat cardiac myocytes, significant amounts of MIF were produced in response to hypoxia and hydrogen peroxide (H2O2), but not to angiotensin II, endothelin-1, interleukin-1β (IL-1β) or tumor necrosis factor {alpha} (TNF{alpha}). H2O2-induced MIF production increased in a time- and dose-dependent manner and was completely abolished in the presence of catalase. H2O2 also induced MIF mRNA expression. The H2O2-induced MIF production was completely inhibited by the protein kinase C (PKC) inhibitor GF109203X, partially inhibited by the tyrosine kinase inhibitor herbimycin A, and uninhibited by calcium chelation or phorbol ester-sensitive PKC down-regulation. This suggests that H2O2-induced MIF production is mediated by an atypical PKC isoform. DNA microarray analysis revealed that 52 genes were preferentially expressed in response to MIF. Of these, the MIF-induced expression of both glutathione S-transferase (GST) and lipopolysaccharide-induced CXC chemokine (LIX) mRNAs was confirmed using RT–PCR analysis. Conclusion: The present results suggest that MIF is expressed by the myocardium in response to redox stress and may play a role in the pathogenesis of myocardial ischemia.

KEYWORDS Cytokines; Hypoxia/anoxia; Reperfusion; Ischemia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H. Morimoto, M. Hirose, M. Takahashi, M. Kawaguchi, H. Ise, P. E. Kolattukudy, M. Yamada, and U. Ikeda
MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species
Cardiovasc Res, June 1, 2008; 78(3): 554 - 562.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Zernecke, J. Bernhagen, and C. Weber
Macrophage Migration Inhibitory Factor in Cardiovascular Disease
Circulation, March 25, 2008; 117(12): 1594 - 1602.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.